AstraZeneca PLC (AZN)
NYSE·Healthcare·Drug Manufacturers - General
$166.43
+0.17%
Mkt Cap $257.66B
Analyst Ratings
No recent rating data.
Price Target (11 analysts)
$186.67
Range $158.00 – $216.00
Implied Upside
+12.2%
Consensus $186.67 vs current $166.43